INTERNATIONAL PATENT: MEMORIAL SLOAN-KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH FILES APPLICATION FOR "METHODS OF USING IL-15 SIGNALING TO ENHANCE NK AND NK-LIKE T CELL FUNCTION AGAINST AML"

GENEVA, Sept. 22 -- MEMORIAL SLOAN-KETTERING CANCER CENTER (1275 York AvenueNew York, New York 10065), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (1275 York AvenueNew York, New York 10065), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (1275 York AvenueNew York, New York 10065) filed a patent application (PCT/US2025/019813) for "METHODS OF USING IL-15 SIGNALING TO ENHANCE NK AND NK-LIKE T CELL FUNCTION AGAINST AML" on Mar 13, 2025. With publication no. WO/2025/193972, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ...